MRI Perfusion Imaging at 3Tx Compared to Invasive FFR Measurements (Vision MRT)
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Coronary artery disease (CAD) has a great significance concerning prevalence and mortality in the western world. It is usually diagnosed by catheterization and coronary arteries are visually assessed by the examiner. Thus having a great spectrum of interobserver differences, especially when it comes to intermediate lesions. The gold standard to assess the haemodynamic significance is the measurement of the myocardial fractional flow reserve (FFR). The FAME-study (Tonino, De Bruyne et al. 2009) was able o show that additional FFR- measurements in patients with intermediate lesions could significantly reduce stent implementation and consequently mortality. However this method is not used in daily routine and is available only in a fraction of catheter labs worldwide. Taking this into account decision finding especially in intermediate lesions remains difficult.
One major step to simplify the invasive approach concerning intermediate lesions would be to establish a non-invasive procedures which localizes the coronary vessel to intervene ahead catheterization.
Do to steady technical development cardiac MRI has become a powerful tool which is able to determine myocardial vitality, perfusion and function. In particular the new generation of 3 Tesla multi transmit MR with its higher field strength and better spatial resolution seems to be able to show first pass myocardial perfusion more precise. With this new technology prefixed to cardiac catheterization clinical relevant information can be made accessible and thus reduce the number of unnecessary implemented stents.
| Condition |
|---|
|
Perfusion Imaging MRI Myocardial Fractional Flow Reserve Myocardial Ischemia |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | MRI Perfusion Imaging at 3T With TX Parallel RF Technology to Identify Myocardial Ischemia Compared to Invasive FFR Measurements |
Eligibility| Ages Eligible for Study: | 18 Years to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
patients with intermediate lesion who underwent cardiac catheterization inluding measurement of the myocardial fractional flow reserve
Inclusion Criteria:
- intermediate lesion defined by myocardial fractional flow reserve measurement
- age > 18 years
Exclusion Criteria:
- pregnancy
- contraindication with adenosin, contrast agents or MR-Scaning
- severe renal dysfunktion
- instable patient(e.g. acute myocardial infarction)
Contacts and Locations| Germany | |
| Heart Center Bogenhausen, Munich Municipal Hospital Group | Recruiting |
| Munich, Bavaria, Germany, 81925 | |
| Contact: Ullrich Ebersberger, MD 0049-89-9270-91 ext 2634 ebersberger@gmx.net | |
| Contact: Alexander Leber, MD 0049-89-9270-91 ext 2773 dr_leber@gmx.de | |
More Information
No publications provided
| Responsible Party: | Alexander Leber, MD, Heart Center Bogenhausen |
| ClinicalTrials.gov Identifier: | NCT01277055 History of Changes |
| Other Study ID Numbers: | HCB10071 |
| Study First Received: | January 13, 2011 |
| Last Updated: | January 13, 2011 |
| Health Authority: | Germany: The Bavarian State Ministry of the Environment and Public Health |
Additional relevant MeSH terms:
|
Myocardial Ischemia Coronary Artery Disease Ischemia Heart Diseases Cardiovascular Diseases |
Vascular Diseases Coronary Disease Arteriosclerosis Arterial Occlusive Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on May 16, 2013